Results 61 to 70 of about 942,109 (243)

Associations of Serum Complement Biomarkers With Adverse Clinical Outcomes Among Patients With Ischemic Stroke

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The complement system plays a crucial role in immune regulation and inflammatory response and is believed to be involved in the onset and progression of ischemic stroke.
Lulu Sun   +11 more
doaj   +1 more source

DIAGNOSTIC SIGNIFICANCE OF IMMUNITY MARKERS IN INFLAMMATORY CARDIOMYOPATHY PATIENTS

open access: yesРоссийский кардиологический журнал, 2017
Aim. To evaluate diagnostic significance of biomarkers for inflammatory cardiomyopathy (ICM).Material and methods. Totally, 35 patients included with suspected inflammatory cardiomyopathy, chronic heart failure of I-III functional class (FC), decreased ...
S. N. Tereschenko   +7 more
doaj   +1 more source

Clinical Characteristics of Patients With IgG4-Related Disease Complicated by Hypocomplementemia

open access: yesFrontiers in Immunology, 2022
BackgroundA proportion of patients with immunogloblin G (IgG) 4-related disease (IgG4-RD) have hypocomplementemia. We aimed to identify characteristics of such patients.MethodsWe analyzed the demographic and clinical data and complement levels of 85 ...
Yuya Fujita   +16 more
doaj   +1 more source

QPTAS and Subexponential Algorithm for Maximum Clique on Disk Graphs [PDF]

open access: yes, 2018
A (unit) disk graph is the intersection graph of closed (unit) disks in the plane. Almost three decades ago, an elegant polynomial-time algorithm was found for Maximum Clique on unit disk graphs [Clark, Colbourn, Johnson; Discrete Mathematics '90]. Since
Bonnet, E.   +4 more
core   +6 more sources

Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections—A Prospective Observational Study

open access: yesFrontiers in Immunology, 2020
Aim: We assessed whether different complement factors and complement activation products were associated with poor outcome in patients with necrotizing soft-tissue infection (NSTI).Methods: We conducted a prospective, observational study in an intensive ...
Markus Korsholm Kristensen   +8 more
doaj   +1 more source

Genome-wide association study for serum complement C3 and C4 levels in healthy Chinese subjects. [PDF]

open access: yesPLoS Genetics, 2012
Complement C3 and C4 play key roles in the main physiological activities of complement system, and their deficiencies or over-expression are associated with many clinical infectious or immunity diseases.
Xiaobo Yang   +28 more
doaj   +1 more source

Combinatorial functions of two chimeric antibodies directed to human CD4 and one directed to the a-chain of the human interleukin-2 receptor [PDF]

open access: yes, 1992
The general feasibility of chimerization of monoclonal antibodies (mAbs) has already been shown for a large number of them. In order to evaluate in vitro parameters relevant to immunosuppressive therapy, we have chimerized and synthesized two anti-CD4 ...
Flieger, Dimitri   +10 more
core   +1 more source

Membranoproliferative glomerulonephritis in patients with chronic venous catheters: a case report and literature review. [PDF]

open access: yes, 2014
Chronic indwelling catheters have been reported to be associated with membranoproliferative glomerulonephritis (MPGN) via the activation of the classical complement pathway in association with bacterial infections such as coagulase negative ...
Nast, Cynthia C   +3 more
core   +2 more sources

Immunoglobulins and complement factor C4 in adult rhinosinusitis

open access: yesClinical and Experimental Immunology, 2006
Summary We assessed whether complement and its factor C4 or abnormal immunoglobulin levels are associated with chronic or recurrent rhinosinusitis. We used multiple patient and control groups to obtain clinically meaningful data. Adult chronic or recurrent rhinosinusitis and acute purulent rhinosinusitis patients were compared with ...
M, Seppänen   +10 more
openaire   +3 more sources

Alternative Complement Pathway Inhibition by Lampalizumab

open access: yesOphthalmology Science, 2023
Purpose: Lampalizumab, an antigen-binding fragment of a humanized monoclonal antibody directed against complement factor D (CFD), is designed to treat geographic atrophy (GA) secondary to age-related macular degeneration.
Rose Edmonds, MS   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy